微软正在全力发展其科研部门
Microsoft Is All In With Growing Its Scientific Research Arm

Microsoft Is All In With Growing Its Scientific Research Arm

微软正在全力发展其科研部门

微软正在对其科研部门进行彻底改革,任命一位资深员工为首位首席科学官。

对于一家科技公司来说,这是一个罕见的举动,但它确实强调了研究对微软业务的重要性。随着公司努力领导人工智能、增强现实和医疗保健技术,科学研究是必不可少的。

微软宣布任命埃里克·霍维茨(Eric Horvitz)为其首席科学官,微软表示,霍维茨将在引导公司的“科学方向和能力”方面发挥关键作用。这意味着霍维茨将负责选择重点领域和将要进行的投资。

霍维茨在一篇博文中表示,该部门将集中精力于生物学、医学信息学、物理、可持续性、经济学以及社会和行为科学。

霍维兹写道:“首席科学家职位的重点是就与科学事务有关的进步和趋势以及科学、技术和社会交叉过程中出现的重要问题和机遇提供跨公司的领导。”

微软将重点放在医疗市场上

作为重组的一部分,微软将把整个部门置于一位曾在其医疗业务中发挥过作用的高管的领导之下。其目的是让微软的医疗产品团队和科学家更好地合作。微软一直在采取行动,将其医疗保健业务整合为一个部门,以进一步进军这一市场。

对于微软来说, 深部研究部门可以带来几笔收入机会.首先是产品开发方面。微软正在创建医疗提供商工具,生产产品,并与医疗行业巨头建立合作关系。

秋季,该公司宣布与诺华结盟,以加快新药的研发进度.这是一个急需修复的地方.目前,一家制药公司推出新药平均需要26亿美元。

3月初,微软在其团队协作和聊天平台上增加了一个新功能,让医疗保健提供商更容易提供虚拟护理。通过新的预约功能, 医疗专业人士可以预订虚拟预约.

自从新的冠状病毒爆发以来, 微软对其团队平台的需求有所增加.仅在中国,微软在隔离期间的使用率就激增了500%。在美国,随着学校和办公室的关闭以及活动被取消,预计上升幅度会更大。

随着医疗服务提供者应对大量病人涌入,新的团队功能也应该得到更多的使用。除此之外,微软还在开发医疗机器人,并创建共享健康记录的API。

云对微软来说很重要

然后是云端微软的云计算业务对其未来的增长至关重要,也是当今巨大的收入来源。

第二季度,Azure收入增长62%。然而,亚马逊是亚马逊亚马逊网络服务的遥远二流玩家。微软希望改变这种状况,并将医疗保健视为实现这一目标的方法之一。

医疗市场上充斥着大量数据,以及如何处理这些数据的新规定。医疗保健公司不堪重负,超负荷工作,因此越来越多地向云提供商寻求帮助。据国际数据公司(IDC)称,去年医疗保健公司预计将在云计算上投入120亿美元。这个数字预计在2020年及以后还会上升。这对微软来说是一个巨大的机会。

为了取得成功,需要创新,这就是研发重点所在。微软不仅为医疗企业提供储存数据的安全场所,而且还需要开发新的服务来帮助它们利用这些信息。

除了向自己的研发投入大量资金外,微软还一直在积极向数字健康初创企业投资。根据CB Insights的数据,在2019年,微软、Alphabet的谷歌和腾讯占了大型科技公司对数字健康初创公司投资的70%。

研发是一家蓬勃发展的科技公司不可或缺的一部分,它希望在未来的岁月里继续存在。微软认识到了这一点,并正在采取行动,以更好地协调这些努力。在越来越不确定的时期,这可能是一个成功的策略。

Microsoft is overhauling its scientific research unit, naming a veteran employee as its first-ever chief scientific officer.

It's an uncommon move for a technology company, but it does underscore the importance of research to Microsoft's operations. As the company strives to lead in artificial intelligence, augmented reality, and healthcare technology, scientific research is necessary.

When announcing the appointment of Eric Horvitz (the director of Microsoft's Research Labs) as its chief scientific officer, Microsoft said Horvitz will play a key role in guiding the company's "scientific directions and capabilities." That means Horvitz will be tasked with choosing the areas to focus on, and the investments to be made.

In a blog post, Horvitz said the unit will concentrate its efforts in biology, medical informatics, physics, sustainability, economics, and the social and behavioral sciences.

"The focus of the chief scientist position is to provide cross-company leadership on advances and trends related to scientific matters and on important issues and opportunities arising at the intersection of science, technology, and society," wrote Horvitz.

Microsoft focuses on the healthcare market with its reorg

As part of the reorganization, Microsoft is putting the entire unit under the leadership of a single executive who has also played a role in its healthcare business. The aim is to enable Microsoft's healthcare product teams and scientists to work better together. Microsoft has been moving to unify its healthcare businesses under one unit, as it pushes further into that market.

For Microsoft, there are several revenue opportunities a deep research arm can bring. There's the product development side, for starters. Microsoft is creating healthcare provider tools, churning out products, and inking partnerships with big names in the healthcare industry.

In the fall it announced an alliance with Novartis to speed the development of new drugs. It's an area in much need of fixing. As it stands, it costs $2.6 billion on average for a pharmaceutical company to introduce a new drug.

Earlier in March, Microsoft added a new feature to its Teams collaboration and chat platform to make it easier for healthcare providers to deliver virtual care. Through the new Bookings feature, healthcare professionals can book virtual appointments.

Since the novel coronavirus outbreak, Microsoft has seen increased demand for its Teams platform. In China alone, Microsoft saw a 500% spike in usage during the quarantines. In the U.S., with schools and offices closing and events getting canceled, Microsoft expects a bigger uptick.

The new Teams feature should also see more usage as healthcare providers contend with an influx of sick patients. On top of that, Microsoft is also developing healthcare bots and creating APIs for sharing health records.

The cloud is big business for Microsoft

Then, there is the cloud side. Microsoft's cloud computing business is extremely important to its future growth and a big revenue driver today.

In its fiscal second quarter, Azure revenue was up 62%. Nevertheless, it is a distant second-place player to Amazon's Amazon Web Services. Microsoft wants to change that, and it views healthcare as one of the ways to do so.

The healthcare market is inundated with data and new regulations around how to handle that data. Healthcare companies are overwhelmed and overworked, and as a result, are increasingly turning to cloud providers for help. According to IDC, healthcare companies were expected to spend $12 billion on the cloud last year. That figure is projected to rise in 2020 and beyond. That's a big opportunity for Microsoft.

In order to succeed, Microsoft will need to innovate, and that's where the R&D focus comes in. Microsoft is not only providing healthcare companies with a safe place to store their data, but it has to come up with new services to help them harness that information.

In addition to pouring money into its own R&D, Microsoft has been actively investing money into digital health startups. According to CB Insights, Microsoft, along with Alphabet's Google and Tencent accounted for 70% of the investments made in digital health startups from big tech companies during 2019.

Research and development is an integral part of a thriving tech company that wants to be around in the years to come. Microsoft recognizes that and is making moves to better align those efforts. In increasingly uncertain times, it may turn out to be a winning strategy.

Microsoft is overhauling its scientific research unit, naming a veteran employee as its first-ever chief scientific officer.

微软正在对其科研部门进行彻底改革,任命一位资深员工为首位首席科学官。

It's an uncommon move for a technology company, but it does underscore the importance of research to Microsoft's operations. As the company strives to lead in artificial intelligence, augmented reality, and healthcare technology, scientific research is necessary.

对于一家科技公司来说,这是一个罕见的举动,但它确实强调了研究对微软业务的重要性。随着公司努力领导人工智能、增强现实和医疗保健技术,科学研究是必不可少的。

When announcing the appointment of Eric Horvitz (the director of Microsoft's Research Labs) as its chief scientific officer, Microsoft said Horvitz will play a key role in guiding the company's "scientific directions and capabilities." That means Horvitz will be tasked with choosing the areas to focus on, and the investments to be made.

微软宣布任命埃里克·霍维茨(Eric Horvitz)为其首席科学官,微软表示,霍维茨将在引导公司的“科学方向和能力”方面发挥关键作用。这意味着霍维茨将负责选择重点领域和将要进行的投资。

In a blog post, Horvitz said the unit will concentrate its efforts in biology, medical informatics, physics, sustainability, economics, and the social and behavioral sciences.

霍维茨在一篇博文中表示,该部门将集中精力于生物学、医学信息学、物理、可持续性、经济学以及社会和行为科学。

"The focus of the chief scientist position is to provide cross-company leadership on advances and trends related to scientific matters and on important issues and opportunities arising at the intersection of science, technology, and society," wrote Horvitz.

霍维兹写道:“首席科学家职位的重点是就与科学事务有关的进步和趋势以及科学、技术和社会交叉过程中出现的重要问题和机遇提供跨公司的领导。”

Microsoft focuses on the healthcare market with its reorg

微软将重点放在医疗市场上

As part of the reorganization, Microsoft is putting the entire unit under the leadership of a single executive who has also played a role in its healthcare business. The aim is to enable Microsoft's healthcare product teams and scientists to work better together. Microsoft has been moving to unify its healthcare businesses under one unit, as it pushes further into that market.

作为重组的一部分,微软将把整个部门置于一位曾在其医疗业务中发挥过作用的高管的领导之下。其目的是让微软的医疗产品团队和科学家更好地合作。微软一直在采取行动,将其医疗保健业务整合为一个部门,以进一步进军这一市场。

For Microsoft, there are several revenue opportunities a deep research arm can bring. There's the product development side, for starters. Microsoft is creating healthcare provider tools, churning out products, and inking partnerships with big names in the healthcare industry.

对于微软来说, 深部研究部门可以带来几笔收入机会.首先是产品开发方面。微软正在创建医疗提供商工具,生产产品,并与医疗行业巨头建立合作关系。

In the fall it announced an alliance with Novartis to speed the development of new drugs. It's an area in much need of fixing. As it stands, it costs $2.6 billion on average for a pharmaceutical company to introduce a new drug.

秋季,该公司宣布与诺华结盟,以加快新药的研发进度.这是一个急需修复的地方.目前,一家制药公司推出新药平均需要26亿美元。

Earlier in March, Microsoft added a new feature to its Teams collaboration and chat platform to make it easier for healthcare providers to deliver virtual care. Through the new Bookings feature, healthcare professionals can book virtual appointments.

3月初,微软在其团队协作和聊天平台上增加了一个新功能,让医疗保健提供商更容易提供虚拟护理。通过新的预约功能, 医疗专业人士可以预订虚拟预约.

Since the novel coronavirus outbreak, Microsoft has seen increased demand for its Teams platform. In China alone, Microsoft saw a 500% spike in usage during the quarantines. In the U.S., with schools and offices closing and events getting canceled, Microsoft expects a bigger uptick.

自从新的冠状病毒爆发以来, 微软对其团队平台的需求有所增加.仅在中国,微软在隔离期间的使用率就激增了500%。在美国,随着学校和办公室的关闭以及活动被取消,预计上升幅度会更大。

The new Teams feature should also see more usage as healthcare providers contend with an influx of sick patients. On top of that, Microsoft is also developing healthcare bots and creating APIs for sharing health records.

随着医疗服务提供者应对大量病人涌入,新的团队功能也应该得到更多的使用。除此之外,微软还在开发医疗机器人,并创建共享健康记录的API。

The cloud is big business for Microsoft

云对微软来说很重要

Then, there is the cloud side. Microsoft's cloud computing business is extremely important to its future growth and a big revenue driver today.

然后是云端微软的云计算业务对其未来的增长至关重要,也是当今巨大的收入来源。

In its fiscal second quarter, Azure revenue was up 62%. Nevertheless, it is a distant second-place player to Amazon's Amazon Web Services. Microsoft wants to change that, and it views healthcare as one of the ways to do so.

第二季度,Azure收入增长62%。然而,亚马逊是亚马逊亚马逊网络服务的遥远二流玩家。微软希望改变这种状况,并将医疗保健视为实现这一目标的方法之一。

The healthcare market is inundated with data and new regulations around how to handle that data. Healthcare companies are overwhelmed and overworked, and as a result, are increasingly turning to cloud providers for help. According to IDC, healthcare companies were expected to spend $12 billion on the cloud last year. That figure is projected to rise in 2020 and beyond. That's a big opportunity for Microsoft.

医疗市场上充斥着大量数据,以及如何处理这些数据的新规定。医疗保健公司不堪重负,超负荷工作,因此越来越多地向云提供商寻求帮助。据国际数据公司(IDC)称,去年医疗保健公司预计将在云计算上投入120亿美元。这个数字预计在2020年及以后还会上升。这对微软来说是一个巨大的机会。

In order to succeed, Microsoft will need to innovate, and that's where the R&D focus comes in. Microsoft is not only providing healthcare companies with a safe place to store their data, but it has to come up with new services to help them harness that information.

为了取得成功,需要创新,这就是研发重点所在。微软不仅为医疗企业提供储存数据的安全场所,而且还需要开发新的服务来帮助它们利用这些信息。

In addition to pouring money into its own R&D, Microsoft has been actively investing money into digital health startups. According to CB Insights, Microsoft, along with Alphabet's Google and Tencent accounted for 70% of the investments made in digital health startups from big tech companies during 2019.

除了向自己的研发投入大量资金外,微软还一直在积极向数字健康初创企业投资。根据CB Insights的数据,在2019年,微软、Alphabet的谷歌和腾讯占了大型科技公司对数字健康初创公司投资的70%。

Research and development is an integral part of a thriving tech company that wants to be around in the years to come. Microsoft recognizes that and is making moves to better align those efforts. In increasingly uncertain times, it may turn out to be a winning strategy.

研发是一家蓬勃发展的科技公司不可或缺的一部分,它希望在未来的岁月里继续存在。微软认识到了这一点,并正在采取行动,以更好地协调这些努力。在越来越不确定的时期,这可能是一个成功的策略。